Paperpal Prime Logo

Experimental and Clinical Psychopharmacology : Impact Factor & More

eISSN: 1936-2293pISSN: 1064-1297

Aims and Scope of Experimental and Clinical Psychopharmacology

Experimental and Clinical Psychopharmacology is a peer-reviewed scientific journal published by the American Psychological Association. It was established in 1993 and covers research in clinical psychology. The current editor-in-chief is William W. Stoops (University of Kentucky Department of Behavioral Science). Less

Key Metrics

CiteScore
4.7
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.96
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Experimental and Clinical Psychopharmacology

Experimental and Clinical Psychopharmacology Journal Specifications

Overview
Publisher AMER PSYCHOLOGICAL ASSOC
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1993
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Experimental and Clinical Psychopharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Experimental and Clinical Psychopharmacology

Gimmie the Gummies: Initial validation of the Edibles Marijuana Purchase Task.
  • 29 Jun 2026
  • Experimental and clinical psychopharmacology
Effects of the neuroactive steroid precursor pregnenolone on stress- and alcohol cue-provoked pain responses in individuals with alcohol use disorder.
  • 8 Jun 2026
  • Experimental and clinical psychopharmacology
Cannabis cues, motives, and attention enhancement: A cannabis priming pilot study.
  • 8 Jun 2026
  • Experimental and clinical psychopharmacology
App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial.
  • 1 Jun 2026
  • Experimental and clinical psychopharmacology
Innovations in health behavior research: Current status and strategic future directions.
  • 1 Jun 2026
  • Experimental and clinical psychopharmacology
Feasibility and acceptability of a trauma-informed and peer-supported digital brief intervention for heavy-drinking emerging adults with interpersonal trauma.
  • 1 Jun 2026
  • Experimental and clinical psychopharmacology
Gimmie the Gummies: Initial validation of the Edibles Marijuana Purchase Task.
  • 29 Jun 2026
  • Experimental and clinical psychopharmacology
Effects of the neuroactive steroid precursor pregnenolone on stress- and alcohol cue-provoked pain responses in individuals with alcohol use disorder.
  • 8 Jun 2026
  • Experimental and clinical psychopharmacology
Cannabis cues, motives, and attention enhancement: A cannabis priming pilot study.
  • 8 Jun 2026
  • Experimental and clinical psychopharmacology
App-based contingency management to reduce heavy drinking days among smokers receiving varenicline: Feasibility, acceptability, and efficacy indicators from a phase I analog trial.
  • 1 Jun 2026
  • Experimental and clinical psychopharmacology
Innovations in health behavior research: Current status and strategic future directions.
  • 1 Jun 2026
  • Experimental and clinical psychopharmacology
Feasibility and acceptability of a trauma-informed and peer-supported digital brief intervention for heavy-drinking emerging adults with interpersonal trauma.
  • 1 Jun 2026
  • Experimental and clinical psychopharmacology

FAQs on Experimental and Clinical Psychopharmacology